Global Dermatology Medications Market Size, by Dermatological Disease (Dermatitis,

Acne, Skin Cancer, Psoriasis, Alopecia), Drug Type (Prescription-Based Drugs, Over-the-
Counter Drugs), Route of Administration (Topical Administration, Oral Administration,
Parenteral Administration), & Region – Key Manufacturers, Analysis, Growth Trends,
and Forecast till 2025

The global dermatology medications market was estimated to be valued at USD XX million in 2018 and
is projected to reach USD XX million/billion by 2025, at a CAGR of XX% during 2019 to 2025. Scope of
global dermatology medications market includes by dermatological disease (Dermatitis, Acne, Skin
Cancer, Psoriasis, Alopecia), by drug type (Prescription-Based Drugs, Over-the-Counter Drugs), by route
of administration (Topical Administration, Oral Administration, Parenteral Administration), and by
region (North America- U.S., Canada; Europe- U.K., France, Germany; Asia-Pacific- China, Japan, India;
Latin America- Brazil, Mexico; Middle East & Africa- South Africa, Saudi Arabia).

Dermatology is the branch of medicine which involves research, diagnosis, prevention, and treatment of
various cosmetic diseases related to skin, hair, nails, and oral and genital membranes by different
investigations and therapies. Dermatology plays a significance role in the field of medicines, as it has
been evaluated that around 15% of world population is suffering from common skin diseases, such as skin
cancers, warts, fungal infections, dermatitis, psoriasis, acne, atopic eczema, and alopecia. Moreover,
various types of medicinal drugs, commonly knowns as dermatological agents are used to treat these skin
disorder, which include prescription-based drugs, and over-the-counter drugs, while topical agents are the
most commonly used treatment, which can be applied directly to the affected area for the desired effects.

However, the rapid increase in the demand for topical dermatological medications such as anti-
inflammatory agents, anti-infective, local anesthetics, cleansers to treat various skin disorders, are the key
factors which stimulate the growth of dermatology medications market over the forecast period.
Furthermore, it has been evaluated that one in six people, which include infants, teenagers, adults, and the
elderly has some type of skin diseases, which are the factors that boost the market growth across the
globe. While the 85% of individuals between ages of 12 and 24 are suffering from some form of acne,
and the people above 30 are suffering from hair problem which are the key factors in increasing the
demand of dermatology medications market across the globe.

However, the lack of awareness of skin disorder and about the drugs are expected to restrain the product
demand over the coming years. The shifting preference of people towards routine skin care to maintain
skin is the key factor providing opportunities to new entrants to invest in the market. Furthermore, the key
players of market are highly focused in manufacturing drugs which are good for hair growth, and can
provide rapid treatment to various skin orders. However, North America is the largest consumer of these
medications due to increasing awareness of skin disorders, while the Asia Pacific region is expected to
have significant growth rate of market due to rapid increase in the skin diseases.
The global dermatology medications market is primarily segmented by dermatological disease, drug type,
route of administration, and region.

In terms of dermatological disease, the market is split into:

* Dermatitis

* Acne

* Skin Cancer

* Psoriasis

* Alopecia

In terms of drug type, the market is divided into:

* Prescription-Based Drugs

* Over-the-Counter Drugs

On the route of administration front, the market is segmented into:

* Topical Administration

* Oral Administration

* Parenteral Administration

The market is classified across regions and countries as follows:

* North America- U.S., Canada

* Europe- Russia, U.K., France, Germany, Italy

* Asia-Pacific- China, Japan, India, Australia

* Latin America- Brazil, Mexico

* Middle East & Africa- South Africa, Egypt, Saudi Arabia

Key Market Players:

The key players profiled in the market include:

* Valeant Pharmaceuticals International

* Merck & Co.

* Novartis AG

* LEO Pharma

* Johnson & Johnson

* AstraZeneca

* Amgen Inc.

* Abbvie Inc.

* Radius Healthcare Private Limited

* Nova Indus Pharmaceuticals

* Trumac Healthcare

* Rezicure Pharmaceuticals

* Mil-Spec Industries Corp.

* International Earth Products LLC

These enterprises have been focusing on development strategies, such as expansions, new product
launches, agreements & partnerships, and acquisitions to expand their business across the globe.

Key Benefits of the Report:

 * Global, regional, country, dermatological disease, route of administration, and drug type market
size and their forecast from 2015-2025

* Identification and detailed analysis and insights on key market dynamics, such as drivers,
opportunities, restraints, and challenges influencing the growth of the market

* Detailed analysis and insights on industry outlook with market specific PESTLE analysis, Porter’s
Five Forces analysis, and Value Chain analysis, to achieve a better understanding of the market and
prepare expansion strategies

* Identification and comprehensive analysis of key market players and their market share, detailed
financial positions, key products, core competencies, and unique selling points

* Identification and analysis of Key players’ competitive developments and strategic initiatives, such
as mergers, joint ventures, sales contracts, and new product introduction in the market

* Expert interviews and their insights on current and future outlook, market shift, and factors
impacting vendors’ short term and long term strategies

* Detailed insights on emerging regions, dermatological disease, route of administration, and drug
type with qualitative and quantitative information and facts

* Identification of the key patents filed in the field of dermatology medications

* Owing to the volatility seen in the market due to the Global COVID-19 pandemic, businesses
around the globe wish to know the impact on their market and how this changes the projections for 2020
and the forthcoming years. Orian Research is in talks with seasoned market analysts and key note
speakers to understand the impact of COVID 19 on markets and factors that will bring in stability in the
foreseeable future

Target Audience:

* Dermatology Medications manufacturer & Technology Providers

* Traders, Importers, and Exporters

* Raw Material Suppliers and Distributors

* Research and Consulting Firms

* Government and Research Organizations

 * Associations and Industry Bodies

Research Methodology:

The market is derived through extensive use of secondary, primary, in-house research followed by expert
validation and third party perspective, such as, analyst reports of investment banks. The secondary
research is the primary base of our study wherein we conducted extensive data mining, referring to
verified data sources, such as, white papers, government and regulatory published articles, technical
journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including
technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity
were taken into consideration. Different weightages have been assigned to these parameters and
quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key
Industry Participants (KIPs), which typically include:

* Manufacturers

* Suppliers

* Distributors

* Raw Material Providers

* Government Body & Associations

* Research Institutes
Table of Content

1. Executive Summary
2. Methodology and Scope
2.1. Market Definition
2.2. Research Methodology
2.3. Research Scope and Assumptions
3. Global Dermatology Medications Market — Market Overview
3.1. Market Segmentation and Scope
3.2. Market Size and Growth Prospects
3.3. Global Dermatology Medications Market — Value Chain Analysis
3.4. Global Dermatology Medications Market — Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Market Opportunity Analysis
3.4.4. Market Challenge Analysis
3.5. Global Dermatology Medications Market – Porter’s Five Forces Analysis
3.5.1. Bargaining Oral Administration of Buyers
3.5.2. Bargaining Oral Administration of Suppliers
3.5.3. Competitive Rivalry
3.5.4. Threat of New Entrants
3.5.5. Threat of Substitutes
3.6. Global Dermatology Medications Market - PESTEL Analysis
3.6.1. Political Factors
3.6.2. Environmental Factors
3.6.3. Social Factors
3.6.4. Technological Factors
3.6.5. Economic Factors
3.6.6. Legal Factors
4. Global Dermatology Medications Market — Industry Trends
4.1. Introduction
4.2. Current Technologies in Dermatology Medications Market
4.3. Emerging Technology Trends in Dermatology Medications Market
4.4. Patent Registrations and Innovations
 4.5. Regulatory Trends in Dermatology Medications Market
5. Global Dermatology Medications Market — Covid-19 Impact Analysis
5.1. Impact of Covid-19 on the Industry
5.2. Impact of Covid-19 on the regions
5.3. Future Opportunities
6. Global Dermatology Medications Market — Dermatological Disease Outlook
6.1. Global Dermatology Medications Market Share, by Dermatological Disease, 2018 &
2025
6.2. Dermatitis
6.2.1. Global Dermatology Medications Market, by Dermatitis, 2015 - 2025
6.3. Acne
6.3.1. Global Dermatology Medications Market, by Acne, 2015 – 2025
6.4. Skin Cancer
6.4.1. Global Dermatology Medications Market, by Skin Cancer, 2015 – 2025
6.5. Psoriasis
6.5.1. Global Dermatology Medications Market, by Psoriasis, 2015 – 2025
6.6. Alopecia
6.6.1. Global Dermatology Medications Market, by Alopecia, 2015 - 2025

7. Global Dermatology Medications Market — Drug type Outlook

7.1. Global Dermatology Medications Market Share, by Drug type, 2018 & 2025
7.2. Prescription-Based Drugs
7.2.1. Global Dermatology Medications Market, by Prescription-Based Drugs, 2015 –
2025
7.3. Over-the-Counter Drugs
7.3.1. Global Dermatology Medications Market, by Over-the-Counter Drugs, 2015 –
2025

8. Global Dermatology Medications Market — Route of administration Outlook

8.1. Global Dermatology Medications Market Share, by Route of administration, 2018 &
2025
8.2. Topical Administration
8.2.1. Global Dermatology Medications Market, by Topical Administration, 2015 - 2025
8.3. Oral Administration
 8.3.1. Global Dermatology Medications Market, by Oral Administration, 2015 – 2025
8.4. Parenteral Administration
8.4.1. Global Dermatology Medications Market, by Parenteral Administration, 2015 –
2025

9. Global Dermatology Medications Market — By Regional Outlook

9.1. Global Dermatology Medications Market Share, by Region, 2018 & 2025
9.2. North America
9.2.1. North America Dermatology Medications Market, by Dermatological disease,
2015 – 2025
9.2.2. North America Dermatology Medications Market, by Drug type, 2015 – 2025
9.2.3. North America Dermatology Medications Market, by Route of administration,
2015 – 2025
9.2.4. North America Dermatology Medications Market, by Country, 2015 – 2025
[Link]. U.S. Dermatology Medications Market, 2015 – 2025
[Link].1. U.S. Dermatology Medications Market, by Dermatological disease,
2015 – 2025
[Link].2. U.S. Dermatology Medications Market, by Drug type, 2015 – 2025
[Link].3. U.S. Dermatology Medications Market, by Route of administration,
2015 – 2025
[Link]. Canada Dermatology Medications Market, 2015 – 2025
[Link].1. Canada Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Canada Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Canada Dermatology Medications Market, by Route of
administration, 2015 – 2025
9.3. Europe
9.3.1. Europe Dermatology Medications Market, by Dermatological disease, 2015 –
2025
9.3.2. Europe Dermatology Medications Market, by Drug type, 2015 – 2025
9.3.3. Europe Dermatology Medications Market, by Route of administration, 2015 –
2025
9.3.4. Europe Dermatology Medications Market, by Country, 2015 – 2025
 [Link]. Russia Dermatology Medications Market, 2015 – 2025
[Link].1. Russia Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Russia Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Russia Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. U.K. Dermatology Medications Market, 2015 – 2025
[Link].1. U.K. Dermatology Medications Market, by Dermatological disease,
2015 – 2025
[Link].2. U.K. Dermatology Medications Market, by Drug type, 2015 – 2025
[Link].3. U.K. Dermatology Medications Market, by Route of administration,
2015 – 2025
[Link]. France Dermatology Medications Market, 2015 – 2025
[Link].1. France Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. France Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. France Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Germany Dermatology Medications Market, 2015 – 2025
[Link].1. Germany Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Germany Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Germany Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Italy Dermatology Medications Market, 2015 – 2025
[Link].1. Italy Dermatology Medications Market, by Dermatological disease,
2015 – 2025
[Link].2. Italy Dermatology Medications Market, by Drug type, 2015 – 2025
[Link].3. Italy Dermatology Medications Market, by Route of administration,
2015 – 2025
9.4. Asia Pacific
9.4.1. Asia Pacific Dermatology Medications Market, by Dermatological disease, 2015 –
2025
9.4.2. Asia Pacific Dermatology Medications Market, by Drug type, 2015 – 2025
9.4.3. Asia Pacific Dermatology Medications Market, by Route of administration, 2015 –
2025
9.4.4. Asia Pacific Dermatology Medications Market, by Country, 2015 – 2025
[Link]. China Dermatology Medications Market, 2015 – 2025
[Link].1. China Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. China Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. China Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Japan Dermatology Medications Market, 2015 – 2025
[Link].1. Japan Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Japan Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Japan Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. India Dermatology Medications Market, 2015 – 2025
[Link].1. India Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. India Dermatology Medications Market, by Drug type, 2015 – 2025
[Link].3. India Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Australia Dermatology Medications Market, 2015 – 2025
[Link].1. Australia Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Australia Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Australia Dermatology Medications Market, by Route of
administration, 2015 – 2025
9.5. Latin America
9.5.1. Latin America Dermatology Medications Market, by Dermatological disease,
2015 – 2025
9.5.2. Latin America Dermatology Medications Market, by Drug type, 2015 – 2025
9.5.3. Latin America Dermatology Medications Market, by Route of administration, 2015
– 2025
9.5.4. Latin America Dermatology Medications Market, by Country, 2015 – 2025
[Link]. Brazil Dermatology Medications Market, 2015 – 2025
[Link].1. Brazil Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Brazil Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Brazil Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Mexico Dermatology Medications Market, 2015 – 2025
[Link].1. Mexico Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Mexico Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Mexico Dermatology Medications Market, by Route of
administration, 2015 – 2025
9.6. Middle East & Africa
9.6.1. Middle East & Africa Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
9.6.2. Middle East & Africa Dermatology Medications Market, by Drug type, 2015 –
2025
Middle East & Africa Dermatology Medications Market, by Route of administration,
2015 – 2025
9.6.3. Middle East & Africa Dermatology Medications Market, by Country, 2015 – 2025
[Link]. South Africa Dermatology Medications Market, 2015 – 2025
[Link].1. South Africa Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. South Africa Dermatology Medications Market, by Drug type, 2015
– 2025
 [Link].3. South Africa Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Egypt Dermatology Medications Market, 2015 – 2025
[Link].1. Egypt Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Egypt Dermatology Medications Market, by Drug type, 2015 –
2025
[Link].3. Egypt Dermatology Medications Market, by Route of
administration, 2015 – 2025
[Link]. Saudi Arabia Dermatology Medications Market, 2015 – 2025
[Link].1. Saudi Arabia Dermatology Medications Market, by Dermatological
disease, 2015 – 2025
[Link].2. Saudi Arabia Dermatology Medications Market, by Drug type,
2015 – 2025
[Link].3. Saudi Arabia Dermatology Medications Market, by Route of
administration, 2015 – 2025
10. Competitive Landscape & Company Profile
10.1. Competitive Landscape
10.1.1. Global Dermatology Medications Market — Market Share/Ranking Analysis, by
Key Players (2018)
10.1.2. Vendor Landscape
10.2. Company Profiles
10.2.1. Valeant Pharmaceuticals International
[Link]. Business Overview
[Link]. Valeant Pharmaceuticals International: Financial Snapshot
[Link]. Products/Services Offered
[Link]. Recent Strategic Initiatives
[Link]. Orian’s View
10.2.2. Merck & Co.
10.2.3. Novartis AG
10.2.4. LEO Pharma
10.2.5. Johnson & Johnson
10.2.6. AstraZeneca
10.2.7. Amgen Inc.
 10.2.8. Abbvie Inc.
10.2.9. Radius Healthcare Private Limited
10.2.10. Nova Indus Pharmaceuticals
10.2.11. Trumac Healthcare
10.2.12. Rezicure Pharmaceuticals

(Note- Business Overview, Financial Snapshot, Products/Services Offered, and Recent Strategic Initiatives will be
provided for each player as per availability. Orian’s view is applicable only for top five publically registered players.)